Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Impetigo - Ozenoxacin Phase lll Trial
Medical News Today
Saturday, January 21, 2012 - 5:18pm
tags:
Ferrer, ozenoxacin
UBS: 8 Pharma Stocks to Watch
The Street
Saturday, January 21, 2012 - 5:11pm
tags:
Teva Pharmaceuticals, Perrigo Company, Mylan, Watson Pharmaceuticals, Hospira, Impax Laboratories, Momenta Pharmaceuticals. Par Pharmaceuticals
Johnson & Johnson's Narrow Trading Range Not Good For Short Term Traders
Seeking Alpha
Saturday, January 21, 2012 - 5:04pm
tags:
JNJ
Carticept nails down $10M to fuel Q1 launch of ultrasound drug delivery system Read more: Carticept nails down $10M to fuel Q1 launch of ultrasound drug delivery system - FierceDrugDelivery http://www.fiercedrugdelivery.com/story/carticept-nails-down-10m
Fierce Drug Delivery
Saturday, January 21, 2012 - 5:01pm
tags:
Carticept, Navigator DS
Is Novartis a Cash King?
Motley Fool
Saturday, January 21, 2012 - 4:50pm
tags:
Novartis
Abbott Labs Wins Ruling Over J&J, Wyeth in Xience Stent Case on Patents
Bloomberg
Saturday, January 21, 2012 - 4:49pm
tags:
Abbott Laboratories, JNJ, Xience stents, stents, Endeavor stents
Skystar Receives Nasdaq Hearings Panel Date
Yahoo/MarketWire
Saturday, January 21, 2012 - 4:46pm
tags:
Skystar Bio-Pharmaceutical
Neutral on Biogen
Yahoo/Zacks
Saturday, January 21, 2012 - 4:45pm
tags:
Biogen Idec
19 Clinical Trials Aren't Enough
Motley Fool
Saturday, January 21, 2012 - 4:44pm
tags:
Dapagliflozin, AstraZeneca, Bristol-Myers Squibb, diabetes
Earnings Preview: J&J to discuss 2012 growth plans
Yahoo/AP
Saturday, January 21, 2012 - 4:43pm
tags:
JNJ
Novartis drug investigated after 11 deaths
Yahoo/AP
Saturday, January 21, 2012 - 1:15pm
tags:
Novartis, Gilenya, multiple sclerosis
J. & J. to Pay $158 Million to End Suit Filed by Texas
New York Times
Saturday, January 21, 2012 - 1:15pm
tags:
JNJ, Risperdal, off label
Pfizer: A Good Defensive Stock Pick
Seeking Alpha
Saturday, January 21, 2012 - 1:14pm
tags:
Pfizer
A Quant's View on the Resignations of TIAA-CREF's President, and the Co-Founder of Vanda Pharmaceuticals
Forbes
Saturday, January 21, 2012 - 1:11pm
tags:
Vanda
CEL-SCI Corporation Releases Letter to Shareholders
Yahoo/BusinessWire
Saturday, January 21, 2012 - 1:08pm
tags:
Cel-Sci, Multikine, head and neck cancer
Biogen, Elan Win U.S. FDA Approval of Tysabri Label Change to Target Use
Bloomberg
Saturday, January 21, 2012 - 1:04pm
tags:
Biogen Idec, Elan, Tysabri, multiple sclerosis
The Giants, Ravens And 49ers Of Biotech
Seeking Alpha
Saturday, January 21, 2012 - 1:03pm
tags:
Halozyme, Jazz Pharmaceuticals, Celgene
Idenix Pharma Buyout Likely: Survey
The Street
Saturday, January 21, 2012 - 12:53pm
tags:
Idenix
Infinity Reports New Data from Phase 1b Trial of Saridegib in Patients with Pancreatic Cancer at ASCO-GI
Yahoo/BusinessWire
Saturday, January 21, 2012 - 12:51pm
tags:
Infinity Pharmaceuticals, saridegib, pancreatic cancer
Exelixis Reports Positive Preliminary Phase 2 Cabozantinib Data in Patients with Hepatocellular Carcinoma
Yahoo/BusinessWire
Saturday, January 21, 2012 - 12:41pm
tags:
Exelixis, cabozantinib, hepatocellular carcinoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.